Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kolb

Showing results (181-190 of 210) with videos related to

Pageof 21
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2023
Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adultsRowan Saloner, Lawren VandeVrede, Breton M Asken, et al.
Journal of Alzheimer'S Disease : JAD|June 12, 2012
A highly selective and specific PET tracer for imaging of tau pathologiesWei Zhang, Janna Arteaga, Daniel K Cashion, et al.
Communications Biology|May 4, 2024
Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's diseaseLazaro M Sanchez-Rodriguez, Gleb Bezgin, Felix Carbonell, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Revealing the combined roles of Aβ and tau in Alzheimer's disease via a pathophysiological activity decoderLazaro M Sanchez-Rodriguez, Gleb Bezgin, Felix Carbonell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 16, 2013
[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's diseaseChun-Fang Xia, Janna Arteaga, Gang Chen, et al.
Journal of Alzheimer'S Disease : JAD|March 15, 2021
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure HydrocephalusHeikki Lukkarinen, Ina Tesseur, Darrel Pemberton, et al.
Science Translational Medicine|November 5, 2025
Beyond Alzheimer's disease-translating biomarker insights across CNS diseasesLinda S Brady, Simin Mahinrad, Rebecca M Edelmayer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 13, 2022
Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuumVincent Doré, James D Doecke, Ziad S Saad, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2018
S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain BiopsiesVille Leinonen, Tuomas Rauramaa, Jarkko Johansson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 10, 2026
Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectoriesRodrigo Cánovas, Christopher J Fowler, Azadeh Feizpour, et al.
Pageof 21

Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2023
Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adultsRowan Saloner, Lawren VandeVrede, Breton M Asken, et al.
Journal of Alzheimer'S Disease : JAD|June 12, 2012
A highly selective and specific PET tracer for imaging of tau pathologiesWei Zhang, Janna Arteaga, Daniel K Cashion, et al.
Communications Biology|May 4, 2024
Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's diseaseLazaro M Sanchez-Rodriguez, Gleb Bezgin, Felix Carbonell, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Revealing the combined roles of Aβ and tau in Alzheimer's disease via a pathophysiological activity decoderLazaro M Sanchez-Rodriguez, Gleb Bezgin, Felix Carbonell, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 16, 2013
[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's diseaseChun-Fang Xia, Janna Arteaga, Gang Chen, et al.
Journal of Alzheimer'S Disease : JAD|March 15, 2021
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure HydrocephalusHeikki Lukkarinen, Ina Tesseur, Darrel Pemberton, et al.
Science Translational Medicine|November 5, 2025
Beyond Alzheimer's disease-translating biomarker insights across CNS diseasesLinda S Brady, Simin Mahinrad, Rebecca M Edelmayer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 13, 2022
Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuumVincent Doré, James D Doecke, Ziad S Saad, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2018
S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain BiopsiesVille Leinonen, Tuomas Rauramaa, Jarkko Johansson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 10, 2026
Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau positron emission tomography trajectoriesRodrigo Cánovas, Christopher J Fowler, Azadeh Feizpour, et al.
Pageof 21